Objectives of this research work were development and validation of HPLC methods of analysis for Bosentan in tablet dosage form from single components as per the current ICH & USP guidelines. HPLC methods also validated for the marketed Bosentan from single components. This developed procedure applied for regular analysis of these medicaments in pharmaceutical industry The major scope of research is development of simple, accurate, reproducible & fast cost effective methods for new cefalosporins. The methods are validated with recovery studies using bulk drug of 80%, 120% & 40%. Specific method is confirmed by checking interference of excipients & assay method. The interday & intraday assay is also performed for checking robustness of the system. The minimum detection limit is checked by using formula LOD = 3.3 sigma (Standnd deviation) / Slop, where σ indicate standard deviation & S denotes slop of the regression straight line. The quantification limit is determined by using LOQ = 10 σ d(St&. dev.)/ S that is minimum concentration of drug can be quantified. Linearity is found in the limit of Beer's law, straight line was constructed within the given range of the conc. of the drugs. So can develop & validate a new, reproducible, correct, & easy, less time consuming, cheap & eco-friendly method for daily analysis of drug in our general life.
INTRODUCTION
Bosentan is used to treat pulmonary hypertension by blocking the action of endothelin molecules that would otherwise promote narrowing of the blood vessels and lead to high blood pressure. Metabolism of Bosentan occurs mainly in the liver by the action of cytochrome P (CYP) 450 3A4 and 2C9, which produces three metabolites: the hydroxylated (hydroxy) metabolite, the demethylated (phenol) metabolite and the hydroxylated and demethylated (hydroxy-phenol) metabolite [1] [2] [3] [4] . Bosentan is chemically, 4-tert-butyl-N-[6-(2-hydroxyethoxy) -5-(2-methoxyphenoxy) -2-(pyrimidin-2-yl) pyrimidin-4-yl] benzene-1 sulfonamide 5 . Various liquid chromatography techniques have been developed for the determination of bosentan in biological fluids [6] [7] and tablet dosage forms 8 . Karnaker RT, et al. (2010) reported RPHPLC procedure for the development & validation of Bosentan present in tab. formulations. The mobile phase was selected on the hit & trial basis. The run time for mobile phase is 1 ml/minutes & gradient technique was used for continue elution of mobile phase according to volume time ratio 8 . The method was developed for bulk drug & then applied for pharmaceutical formulations. The method is validated for recovery studies (40, 80, 120%), linearity, (preparation of standard curve), detection of limit, limit of quantification, stability studies on temperature basis, specificity of instruments. The method was applied for routine analysis of drugs 10 .
In the present study a simple, rapid, precise and accurate stability indicating liquid chromatographic method was developed for the determination of BST in in tablet dosage forms and validated as per ICH guidelines.
MATERIAL AND METHODS:
1. Analytical Method Development 10,11
Equipments
The following instruments & equipments were used during the development studies: 
HPLC instrument
Waters 2695 separations module with 2487/2489 dual wavelength absorbance detector with Empower chromatographic software.
pH meter
Thermo-Orion star series
Analytical balance
Mettler Toledo Ultrasonic bath POWER SONIC420 "Aarkey"
Water purification System
Milli Q Gradient A 10 ,Elix A 10 "Millipore"
Reagents & Chemicals
The following reagents & chemicals were used during the validation studies: 
Working Standard
The following Working standard was used during the develop studies:
Bosentan in Salt form: Potency (%) 98.8
Parameter Wise Method Development Plan
A. Molecular weight: 
Scope:
This validation study is applicable for Assay method of Bosentan, which will be used to ensure the identity, quality & purity of active pharmaceutical ingredient.
Methodology

Preparation of mobile phase-A
Dissolved 1.36 gm of potassium dihydrogen phosphate to 1000 mL of HPLC grade water. Mixed well using a magnetic stirrer bar until completely mixed. The solution was filtered through a 0.45 m nylon membrane filter & degassed.
Preparation of mobile phase-B:
Acetonitrile (HPLC Grade)
Preparation of standard solution
Weighed accurately about 48 mg of Bosentan working/reference standard into 50 mL volumetric flask. Dissolve in 30 mL of Methanol & dilute to volume with methanol. Diluted 5 ml of this solution to 50 ml Methanol
Preparation of sample solution
5 Intact tablet of Bosentan taken into 500 ml volumetric flask than added 10 ml of water & sonicate till disintegrated. Added about 400 ml of methanol & sonicated for 45 minutes than made up volume with methanol. Added 5 ml of this solution in to 50 ml volumetric flask & make up volume with methanol. Injections of working standard solution should not be more than 2%.
System Precision 12
Chromatographic conditions
2. The tailing factor of standard peak should not be more than2.0 3. The plate count of standard peak should be more than 2000.
Method Precision:
Methodology: 5 intact tablet of Bosentan taken into 500 ml volumetric flask than added 10 ml of water & sonicate till disintegrated. Added about 400 ml of methanol & sonicated for 45 minutes than made up volume with methanol. Added 5 ml of this solution in to 50 ml volumetric flask & make up volume with methanol.
The sample was prepared six times as per above methodology & injected in duplicate into the HPLC system.
Linearity
Prepared system suitability solution & diluted standard solution as per STP. Injected blank, system suitability solution & diluted standard solution as per injection sequence. Checked the acceptance criteria for system suitability.
Preparation of Linearity Stock Solution
Weighed 99.52 gm of working standard in 100 ml volumetric flask. Added 30 ml of methanol & sonicated to dissolve. Made up volume with methanol.
Prepared Linearity solution of 20%, 80%, 120%, 160%, 240% by dilution of Linearity Stock solution as below
Conc. (µg/mL) =
Wt. taken (mg) x Volume of Stock Solution taken (mL) x Potency of St&ard (on as is basis) x (Molecular Weight of Drug 'X') x1000 ------------------------------------------------------------------------------------------------------------------------------------------------100 mL x Dilution (mL) x Molecular Weight of Bosentan salt form x 100
Acceptance criteria: Acceptance criteria for system suitability should pass. Correlation coefficient should not be less than 0.990. Linearity has passed as accepted criteria. 
RESULTS AND DISCUSSION
In order to get the increased efficiency of the chromatographic system, the conditions of experiment such as column, column temp, pH and composition of mobile phase, and detection wavelength were optimized by changing one parameter at a time and keeping the other parameters constant. In RP HPLC method, the primary requirement for developing a method for analysis is that the using different solvents and buffers and columns to get better retention time and theoretical plates, and better cost effective and time saving method than the previously developed methods.
Method Development Trials
Trial no.-1 
Chromatograms of Standard:
Injection-1
Injection-2
Injection-3
Injection-4
Injection-5
Injection-6 . Using the chromatography data acquisition system, integrate the peaks of standard solution.
System suitability passes as per acceptance criteria.
Method Precision:
5 
